BIIB insider trading
Open-market stock trades by Biogen (BIIB) executives and directors: who bought or sold, how many shares, at what price and when.
BIIB insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Minor Lloyd | director | Sell | 593 | $203.34 | $120.58K |
| Aug 4, 2026 | Minor Lloyd | director | Sell | 593 | $200.96 | $119.17K |
| Feb 12, 2026 | Murphy Nicole | Head of Pharm Ops and Tech | Buy | 3 | $195.03 | $585.11 |
| Feb 9, 2026 | Singhal Priya | Head of Development | Sell | 2,660 | $199.83 | $531.55K |
- BIIB insiders bought $585.11 and sold $771.30K in open-market trades over their last 4 filings.
Updated 2026-11-02 23:12 UTC